LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Sapience Therapeutics, Inc.…

Similar companies to Sapience Therapeutics, Inc.

Sapience Therapeutics, Inc. Tech Stack

Sapience Therapeutics, Inc. uses 8 technology products and services including WordPress, oEmbed, Backbone.js, and more. Explore Sapience Therapeutics, Inc.'s tech stack below.

  • WordPress
    Content Management System
  • oEmbed
    Dev Tools
  • Backbone.js
    Javascript Frameworks
  • DocuSign
    Miscellaneous
  • On-Site
    Real Estate Property Management
  • Google Tag Manager
    Tag Management
  • USPS
    Transportation And Fleet Management
  • Google Analytics
    Web Analytics

Media & News

Sapience Therapeutics, Inc.'s Email Address Formats

Sapience Therapeutics, Inc. uses at least 1 format(s):
Sapience Therapeutics, Inc. Email FormatsExamplePercentage
FLast@sapiencetherapeutics.comJDoe@sapiencetherapeutics.com
65%
First@sapiencetherapeutics.comJohn@sapiencetherapeutics.com
18%
Last@sapiencetherapeutics.comDoe@sapiencetherapeutics.com
12%
FirstLast@sapiencetherapeutics.comJohnDoe@sapiencetherapeutics.com
5%

Frequently Asked Questions

Where is Sapience Therapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign iconSapience Therapeutics, Inc.'s main headquarters is located at 520 White Plains Road, Second Floor. The company has employees across 1 continents, including North America.

What is Sapience Therapeutics, Inc.'s phone number?

Minus sign iconPlus sign icon You can contact Sapience Therapeutics, Inc.'s main corporate office by phone at
+1-914-607-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Sapience Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign iconSapience Therapeutics, Inc.'s official website is sapiencetherapeutics.com and has social profiles on LinkedInCrunchbase.

What is Sapience Therapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconSapience Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Sapience Therapeutics, Inc. have currently?

Minus sign iconPlus sign iconAs of December 2025, Sapience Therapeutics, Inc. has approximately 33 employees across 1 continents, including North America. Key team members include Chief Medical Officer: A. V.Chief Scientific Officer: J. R.Chief Financial Officer: M. F.. Explore Sapience Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Sapience Therapeutics, Inc. belong to?

Minus sign iconPlus sign iconSapience Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Sapience Therapeutics, Inc. use?

Minus sign iconPlus sign iconSapience Therapeutics, Inc.'s tech stack includes WordPressoEmbedBackbone.jsDocuSignOn-SiteGoogle Tag ManagerUSPSGoogle Analytics.

What is Sapience Therapeutics, Inc.'s email format?

Minus sign iconPlus sign iconSapience Therapeutics, Inc.'s email format typically follows the pattern of FLast@sapiencetherapeutics.com. Find more Sapience Therapeutics, Inc. email formats with LeadIQ.

How much funding has Sapience Therapeutics, Inc. raised to date?

Minus sign iconPlus sign icon As of December 2025, Sapience Therapeutics, Inc. has raised $2M in funding. The last funding round occurred on May 04, 2023 for $2M.

When was Sapience Therapeutics, Inc. founded?

Minus sign iconPlus sign iconSapience Therapeutics, Inc. was founded in 2015.

Sapience Therapeutics, Inc.

Biotechnology ResearchNew York, United States11-50 Employees

At Sapience, we think boldly about the possibilities for treating cancer. We aim to discover and develop peptide therapeutics to address oncogenic and immunogenic dysregulation that drive cancer.  Our pipeline of SPEARs™ (Stabilized Peptides Engineered Against Regulation) disrupt intracellular protein-protein interactions, enabling targeting of transcription factors which have traditionally been considered undruggable. We are advancing our lead programs, ST316, a first-in-class antagonist of β-catenin, and lucicebtide (formerly known as ST101), a first-in-class antagonist of C/EBPβ, through Phase 2 clinical trials.  Please engage with us on this platform to learn more!

Section iconCompany Overview

Headquarters
520 White Plains Road, Second Floor
Phone number
+1-914-607-****
Website
sapiencetherapeutics.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $2M

    Sapience Therapeutics, Inc. has raised a total of $2M of funding over 7 rounds. Their latest funding round was raised on May 04, 2023 in the amount of $2M.

  • $10M$25M

    Sapience Therapeutics, Inc.'s revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $2M

    Sapience Therapeutics, Inc. has raised a total of $2M of funding over 7 rounds. Their latest funding round was raised on May 04, 2023 in the amount of $2M.

  • $10M$25M

    Sapience Therapeutics, Inc.'s revenue is estimated to be in the range of $10M$25M

Company Leadership

  • Stylized image of a person
    A. V.
    Chief Medical Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. R.
    Chief Scientific Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. F.
    Chief Financial Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    N. D.
    Chief Administrative Officer & Corporate Controller
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. K.
    Founder, President And Ceo
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    G. M.
    Svp Of Cmc And Operations
    Phone icon
    Mobile Phone
  • Stylized image of a person
    F. A.
    Director, Translational Sciences
    Phone icon
    Mobile Phone
  • Stylized image of a person
    C. S.
    Associate Director
    Phone icon
    Mobile Phone
  • Stylized image of a person
    L. G.
    Executive Director
    Phone icon
    Mobile Phone
  • Stylized image of a person
    E. D. D.
    Associate Director Quality Assurance
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.